{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:23:50Z","timestamp":1790065430559,"version":"4.0.1"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP130702"],"award-info":[{"award-number":["RP130702"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Texas Health Catalyst Program of the Dell Medical School at The University of Texas at Austin"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.addr.2017.06.008","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T08:31:36Z","timestamp":1497601896000},"page":"175-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"special_numbering":"C","title":["Combinatorial immunotherapy and nanoparticle mediated hyperthermia"],"prefix":"10.1016","volume":"114","author":[{"given":"Austin J.","family":"Moy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Tunnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2017.06.008_bb0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.addr.2017.06.008_bb0010","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.addr.2017.06.008_bb0015","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with Ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2017.06.008_bb0020","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1200\/JCO.2014.56.6018","article-title":"Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trial","volume":"33","author":"Maio","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.addr.2017.06.008_bb0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1305133","article-title":"Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma","volume":"369","author":"Hamid","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2017.06.008_bb0030","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2017.06.008_bb0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined Nivolumab and Ipilimumab or Monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2017.06.008_bb0040","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.addr.2017.06.008_bb0045","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1172\/JCI87324","article-title":"Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma","volume":"126","author":"Daud","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2017.06.008_bb0050","doi-asserted-by":"crossref","unstructured":"P. Sharma, J.P. Allison, Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential, Cell 161 (n.d.) 205\u2013214. doi:http:\/\/dx.doi.org\/10.1016\/j.cell.2015.03.030.","DOI":"10.1016\/j.cell.2015.03.030"},{"key":"10.1016\/j.addr.2017.06.008_bb0055","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saint Victor","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.addr.2017.06.008_bb0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrc1613","article-title":"Immunotherapy and chemotherapy \u2014 a practical partnership","volume":"5","author":"Lake","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.addr.2017.06.008_bb0065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1053\/j.seminoncol.2015.05.007","article-title":"Immune effects of chemotherapy, radiation, and targeted therapy and opportunities for combination with immunotherapy","volume":"42","author":"Wargo","year":"2015","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.addr.2017.06.008_bb0070","doi-asserted-by":"crossref","first-page":"13549","DOI":"10.1073\/pnas.2232479100","article-title":"Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance","volume":"100","author":"Hirsch","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2017.06.008_bb0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/153303460400300104","article-title":"Nanoshell-enabled photonics-based imaging and therapy of cancer","volume":"3","author":"Loo","year":"2004","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.addr.2017.06.008_bb0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.canlet.2004.02.004","article-title":"Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles","volume":"209","author":"O'Neal","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.addr.2017.06.008_bb0085","unstructured":"Pilot study of AuroLase(tm) therapy in refractory and\/or recurrent tumors of the head and neck - full text view - ClinicalTrials.gov, (n.d.). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00848042?term=auroshell&rank=2 (accessed February 27, 2017)."},{"key":"10.1016\/j.addr.2017.06.008_bb0090","unstructured":"MRI\/US fusion imaging and biopsy in combination with nanoparticle directed focal therapy for ablation of prostate tissue - full text view - ClinicalTrials.gov, (n.d.). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02680535?term=auroshell&rank=1 (accessed February 27, 2017)."},{"key":"10.1016\/j.addr.2017.06.008_bb0095","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/02656730500158360","article-title":"Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique","volume":"21","author":"Johannsen","year":"2005","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2017.06.008_bb0100","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1349-7006.2003.tb01438.x","article-title":"Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma","volume":"94","author":"Ito","year":"2003","journal-title":"Cancer Sci."},{"key":"10.1016\/j.addr.2017.06.008_bb0105","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1080\/02656730500340794","article-title":"How is the immune response affected by hyperthermia and heat shock proteins?","volume":"21","author":"Calderwood","year":"2005","journal-title":"Int. J. Hyperth."},{"issue":"10","key":"10.1016\/j.addr.2017.06.008_bb0110","first-page":"550","article-title":"Hyperthermia as an immunotherapy strategy for cancer","volume":"2000","author":"Skitzki","year":"2009","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.addr.2017.06.008_bb0115","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/02656736.2012.677933","article-title":"Old and new facts about hyperthermia-induced modulations of the immune system","volume":"28","author":"Frey","year":"2012","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2017.06.008_bb0120","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1126\/science.1209038","article-title":"The unfolded protein response: from stress pathway to homeostatic regulation","volume":"334","author":"Walter","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.addr.2017.06.008_bb0125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/sj.cdd.4401510","article-title":"Dual function of membrane-bound heat shock protein 70 (Hsp70), Bag-4, and Hsp40: protection against radiation-induced effects and target structure for natural killer cells","volume":"12","author":"Gehrmann","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.addr.2017.06.008_bb0130","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1126\/science.7545313","article-title":"A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides","volume":"269","author":"Suto","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.addr.2017.06.008_bb0135","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.4049\/jimmunol.1002991","article-title":"Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine","volume":"186","author":"Chen","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2017.06.008_bb0140","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1080\/0265673021000017109","article-title":"Activation of natural killer cells by heat shock protein 70","volume":"18","author":"Multhoff","year":"2002","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2017.06.008_bb0145","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2217\/nnm.12.142","article-title":"T-cell receptor repertoires of tumor-infiltrating lymphocytes after hyperthermia using functionalized magnetite nanoparticles","volume":"8","author":"Ito","year":"2013","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.addr.2017.06.008_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1449","article-title":"Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment","author":"Riley","year":"2017","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.addr.2017.06.008_bb0155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/smll.201000134","article-title":"A new era for cancer treatment: gold-nanoparticle-mediated thermal therapies","volume":"7","author":"Kennedy","year":"2011","journal-title":"Small"},{"key":"10.1016\/j.addr.2017.06.008_bb0160","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.4155\/tde.11.72","article-title":"Nanoparticle-mediated hyperthermia in cancer therapy","volume":"2","author":"Chatterjee","year":"2011","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.addr.2017.06.008_bb0165","doi-asserted-by":"crossref","first-page":"074001","DOI":"10.1115\/1.3156800","article-title":"Nanoparticles for thermal cancer therapy","volume":"131","author":"Day","year":"2009","journal-title":"J. Biomech. Eng."},{"key":"10.1016\/j.addr.2017.06.008_bb0170","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1021\/cr400532z","article-title":"Functional nanomaterials for phototherapies of cancer","volume":"114","author":"Cheng","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.addr.2017.06.008_bb0175","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1021\/ja057254a","article-title":"Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods","volume":"128","author":"Huang","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2017.06.008_bb0180","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10103-007-0470-x","article-title":"Plasmonic photothermal therapy (PPTT) using gold nanoparticles","volume":"23","author":"Huang","year":"2008","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.addr.2017.06.008_bb0185","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.canlet.2008.04.026","article-title":"Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice","volume":"269","author":"Dickerson","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.addr.2017.06.008_bb0190","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.nano.2013.09.011","article-title":"Gold nanoparticle mediated cancer immunotherapy","volume":"10","author":"Almeida","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2017.06.008_bb0195","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1021\/nl201400z","article-title":"Copper selenide nanocrystals for photothermal therapy","volume":"11","author":"Hessel","year":"2011","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2017.06.008_bb0200","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2217\/nnm.10.85","article-title":"Copper sulfide nanoparticles for photothermal ablation of tumor cells","volume":"5","author":"Li","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2017.06.008_bb0205","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1021\/nl100996u","article-title":"Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy","volume":"10","author":"Yang","year":"2010","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2017.06.008_bb0210","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2147\/IJN.S116583","article-title":"Conductive polymer-based nanoparticles for laser-mediated photothermal ablation of cancer: synthesis, characterization, and in vitro evaluation","volume":"12","author":"Cantu","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2017.06.008_bb0215","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.1002\/adma.201202625","article-title":"In vitro and in vivo near-infrared photothermal therapy of cancer using polypyrrole organic nanoparticles","volume":"24","author":"Yang","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2017.06.008_bb0220","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/lsm.20968","article-title":"Single-wall carbon nanotubes assisted photothermal cancer therapy: animal study with a murine model of squamous cell carcinoma","volume":"42","author":"Huang","year":"2010","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.addr.2017.06.008_bb0225","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/wnan.1322","article-title":"Therapeutic gold, silver, and platinum nanoparticles","volume":"7","author":"Yamada","year":"2015","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.addr.2017.06.008_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17091534","article-title":"Silver nanoparticles: synthesis, characterization, properties, applications, and therapeutic approaches","volume":"17","author":"Zhang","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2017.06.008_bb0235","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1016\/j.biomaterials.2013.03.077","article-title":"Platinum nanoparticles for the photothermal treatment of Neuro 2A cancer cells","volume":"34","author":"Manikandan","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2017.06.008_bb0240","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/lsm.22072","article-title":"Nanoparticle-mediated photothermal therapy: a comparative study of heating for different particle types","volume":"44","author":"Pattani","year":"2012","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.addr.2017.06.008_bb0245","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.nano.2014.10.005","article-title":"Biodistribution and in vivo toxicity of aptamer-loaded gold nanostars","volume":"11","author":"Dam","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2017.06.008_bb0250","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7150\/thno.6630","article-title":"Multifunctional gold nanostar conjugates for tumor imaging and combined photothermal and chemo-therapy","volume":"3","author":"Chen","year":"2013","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2017.06.008_bb0255","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1021\/nn304332s","article-title":"Comparison study of gold nanohexapods, nanorods, and nanocages for photothermal cancer treatment","volume":"7","author":"Wang","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2017.06.008_bb0260","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1021\/nl050127s","article-title":"Immunotargeted nanoshells for integrated cancer imaging and therapy","volume":"5","author":"Loo","year":"2005","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2017.06.008_bb0265","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1117\/1.3290817","article-title":"Photothermal therapy in a murine colon cancer model using near-infrared absorbing gold nanorods","volume":"15","author":"Goodrich","year":"2010","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.addr.2017.06.008_bb0270","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1158\/1078-0432.CCR-08-1480","article-title":"Targeted Photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog\u2013conjugated hollow gold nanospheres","volume":"15","author":"Lu","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2017.06.008_bb0275","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/adhm.201501035","article-title":"Cancer cell internalization of gold nanostars impacts their photothermal efficiency in vitro and in vivo: toward a plasmonic thermal fingerprint in tumoral environment","volume":"5","author":"Espinosa","year":"2016","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2017.06.008_bb0280","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/00000658-195710000-00007","article-title":"Selective inductive heating of lymph nodes","volume":"146","author":"Gilchrist","year":"1957","journal-title":"Ann. Surg."},{"key":"10.1016\/j.addr.2017.06.008_bb0285","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/btm2.10003","article-title":"Nanoparticles in the clinic","volume":"1","author":"Anselmo","year":"2016","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.addr.2017.06.008_bb0290","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2147\/IJN.S10458","article-title":"Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells","volume":"5","author":"Wu","year":"2010","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2017.06.008_bb0295","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.biomaterials.2010.11.028","article-title":"Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy","volume":"32","author":"Yallapu","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2017.06.008_bb0300","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijpharm.2010.10.038","article-title":"Tumor selectivity of stealth multi-functionalized superparamagnetic iron oxide nanoparticles","volume":"404","author":"Fan","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2017.06.008_bb0305","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.biomaterials.2009.09.091","article-title":"The in vivo performance of magnetic particle-loaded injectable, in situ gelling, carriers for the delivery of local hyperthermia","volume":"31","author":"Le Renard","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2017.06.008_bb0310","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.apsusc.2014.04.018","article-title":"Folic acid-conjugated Fe3O4 magnetic nanoparticles for hyperthermia and MRI in vitro and in vivo","volume":"307","author":"Jiang","year":"2014","journal-title":"Appl. Surf. Sci."},{"key":"10.1016\/j.addr.2017.06.008_bb0315","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.matchemphys.2012.12.044","article-title":"PEG-coated folic acid-modified superparamagnetic MnFe2O4 nanoparticles for hyperthermia therapy and drug delivery","volume":"138","author":"Shah","year":"2013","journal-title":"Mater. Chem. Phys."},{"key":"10.1016\/j.addr.2017.06.008_bb0320","first-page":"319","article-title":"Hyperthermia using antibody-conjugated magnetic nanoparticles and its enhanced effect with cryptotanshinone","volume":"4","author":"Ota","year":"2014","journal-title":"Nano"},{"key":"10.1016\/j.addr.2017.06.008_bb0325","doi-asserted-by":"crossref","DOI":"10.3402\/nano.v1i0.5358","article-title":"Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)","volume":"1","author":"Singh","year":"2010","journal-title":"Nano Rev."},{"key":"10.1016\/j.addr.2017.06.008_bb0330","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3109\/02656736.2013.834384","article-title":"Magnetic fluid hyperthermia for bladder cancer: a preclinical dosimetry study","volume":"29","author":"Oliveira","year":"2013","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.addr.2017.06.008_bb0335","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3171\/2014.2.SPINE13142","article-title":"Characterization of intratumor magnetic nanoparticle distribution and heating in a rat model of metastatic spine disease","volume":"20","author":"Zadnik","year":"2014","journal-title":"J. Neurosurg. Spine"},{"key":"10.1016\/j.addr.2017.06.008_bb0340","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13058-015-0576-1","article-title":"Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery","volume":"17","author":"Kossatz","year":"2015","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.addr.2017.06.008_bb0345","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3892\/ol.2014.1893","article-title":"Magnetic fluid hyperthermia inhibits the growth of breast carcinoma and downregulates vascular endothelial growth factor expression","volume":"7","author":"Wang","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.addr.2017.06.008_bb0350","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1245\/ASO.2003.07.017","article-title":"Radiofrequency ablation of malignant liver tumors","volume":"10","author":"Curley","year":"2003","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.addr.2017.06.008_bb0355","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJM199902183400707","article-title":"Radio-frequency ablation as treatment for cardiac arrhythmias","volume":"340","author":"Morady","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2017.06.008_bb0360","first-page":"313","article-title":"Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles","volume":"7","author":"Curley","year":"2008","journal-title":"J. Exp. Ther. Oncol."},{"key":"10.1016\/j.addr.2017.06.008_bb0365","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1477-3155-6-2","article-title":"Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells","volume":"6","author":"Gannon","year":"2008","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2017.06.008_bb0370","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1038\/srep07034","article-title":"Radio frequency radiation-induced hyperthermia using Si nanoparticle-based sensitizers for mild cancer therapy","volume":"4","author":"Tamarov","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.addr.2017.06.008_bb0375","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/cncr.23155","article-title":"Carbon nanotube-enhanced thermal destruction of cancer cells in a noninvasive radiofrequency field","volume":"110","author":"Gannon","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.addr.2017.06.008_bb0380","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/676957","article-title":"Non-invasive radiofrequency-induced targeted hyperthermia for the treatment of hepatocellular carcinoma","volume":"2011","author":"Raoof","year":"2011","journal-title":"Int. J. Hepatol."},{"key":"10.1016\/j.addr.2017.06.008_bb0385","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1158\/1078-0432.CCR-10-2055","article-title":"Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma Xenografts treated with targeted gold nanoparticles","volume":"16","author":"Glazer","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2017.06.008_bb0390","series-title":"Adv. Heat Transf","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/bs.aiht.2015.09.001","article-title":"Chapter six - evolution of thermal dosimetry for application of hyperthermia to treat cancer","author":"Dewhirst","year":"2015"},{"key":"10.1016\/j.addr.2017.06.008_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11051-014-2822-3","article-title":"Role of apoptosis and necrosis in cell death induced by nanoparticle-mediated photothermal therapy","volume":"17","author":"Pattani","year":"2015","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.addr.2017.06.008_bb0400","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.nano.2014.01.011","article-title":"Local hyperthermia treatment of tumors induces CD8(+) T cell-mediated resistance against distal and secondary tumors","volume":"10","author":"Toraya-Brown","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2017.06.008_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069073","article-title":"Elimination of metastatic melanoma using gold nanoshell-enabled Photothermal therapy and adoptive T cell transfer","volume":"8","author":"Bear","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2017.06.008_bb0410","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1021\/nn100736c","article-title":"In vivo molecular photoacoustic tomography of melanomas targeted by bioconjugated gold nanocages","volume":"4","author":"Kim","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2017.06.008_bb0415","first-page":"12278","article-title":"Antibody-drug conjugates: targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin","volume":"5","author":"Falvo","year":"2013","journal-title":"Nano"},{"key":"10.1016\/j.addr.2017.06.008_bb0420","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature08956","article-title":"Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles","volume":"464","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.addr.2017.06.008_bb0425","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1016\/S0142-9612(03)00343-0","article-title":"RGD modified polymers: biomaterials for stimulated cell adhesion and beyond","volume":"24","author":"Hersel","year":"2003","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.addr.2017.06.008_bb0430","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2147\/IJN.S15479","article-title":"Integrin \u03b1(v)\u03b2(3)-targeted gold nanoshells augment tumor vasculature-specific imaging and therapy","volume":"6","author":"Xie","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2017.06.008_bb0435","doi-asserted-by":"crossref","first-page":"260ra149","DOI":"10.1126\/scitranslmed.3009524","article-title":"Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe","volume":"6","author":"Phillips","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2017.06.008_bb0440","first-page":"4295","article-title":"Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats","volume":"62","author":"Chen","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2017.06.008_bb0445","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3835(97)04707-1","article-title":"Laser-photosensitizer assisted immunotherapy: a novel modality for cancer treatment","volume":"115","author":"Chen","year":"1997","journal-title":"Cancer Lett."},{"key":"10.1016\/j.addr.2017.06.008_bb0450","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.4161\/cbt.10.11.13434","article-title":"Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients","volume":"10","author":"Li","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.addr.2017.06.008_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2015.01.029","article-title":"InCVAX \u2013 a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity","volume":"359","author":"Zhou","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.addr.2017.06.008_bb0460","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1039\/c0pp00306a","article-title":"Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients","volume":"10","author":"Li","year":"2011","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.addr.2017.06.008_bb0465","doi-asserted-by":"crossref","first-page":"8154","DOI":"10.1002\/adma.201402996","article-title":"Immunological responses triggered by photothermal therapy with carbon nanotubes in combination with anti-CTLA-4 therapy to inhibit cancer metastasis","volume":"26","author":"Wang","year":"2014","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2017.06.008_bb0470","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.nano.2016.10.015","article-title":"Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma","volume":"13","author":"Cano-Mejia","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2017.06.008_bb0475","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1038\/ncomms13193","article-title":"Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy","volume":"7","author":"Chen","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2017.06.008_bb0480","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1021\/nn403202w","article-title":"A comparative study of hollow copper sulfide nanoparticles and hollow gold nanospheres on degradability and toxicity","volume":"7","author":"Guo","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2017.06.008_bb0485","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1021\/nn5002112","article-title":"Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticles","volume":"8","author":"Guo","year":"2014","journal-title":"ACS Nano"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X17300923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X17300923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T01:51:56Z","timestamp":1569462716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X17300923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":97,"alternative-id":["S0169409X17300923"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2017.06.008","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combinatorial immunotherapy and nanoparticle mediated hyperthermia","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2017.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}